Real-world safety profile of eravacycline compared with tigecycline, minocycline, and meropenem: a comparative pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS)

Naunyn-Schmiedeberg s Archives of Pharmacology 2026

View at publisher

Authors: Yan Chen, Yi Xu, Feifei Hou, Jianfeng Wang

DOI: 10.1007/s00210-026-05811-x

Cited by: 1

References: 29

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions Pharmaceutical and Antibiotic Environmental Impacts Antibiotic Use and Resistance

References 29